Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

University Of Queesnland's Speech Pathology Students Teach The Art Of Smooth Talking, Australia
A group of UQ speech pathology students recently ran an intensive treatment program for people who stutter.

Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging Clinical Study Of Pramlintide/Metreleptin Combination Treatment For Obesity
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, in overweight and obese patients. This Phase 2 study successfully characterized patients who responded best to treatment and also provided important information to inform dose selection.
News of the day
Emergent BioSolutions Meets With FDA To Review Regulatory Strategy For Recombinant Anthrax Vaccine
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has met with the U.S. Food and Drug Administration (FDA) to review Emergent"s regulatory strategy for the development of its recombinant anthrax (rPA) vaccine. Emergent recently submitted to FDA, among other documents, its rPA Development Plan in response to the Department of Health and Human Services" (HHS) amendment to its request for proposal (RFP) to develop and deliver up to 25 million doses of an rPA vaccine for the Strategic National Stockpile. In amending the RFP, HHS required that all bidders deemed to be in the competitive range submit to FDA a comprehensive plan outlining the regulatory strategy for their rPA vaccine. Emergent completed that submission on May 12, 2009 ahead of the June 15, 2009 submission deadline.
Mental Health

Journal Of Dietary Supplements

Natural Standard Research Collaboration invites researchers to submit articles to Journal of Dietary Supplements (JDS) - an international peer-reviewed forum for original research and review articles that focus on vitamins, minerals, herbs and other substances that make up the multi-billion dollar dietary supplement industry. The journal addresses important issues that meet a broad range of interests - not only in integrative healthcare, but also in academic, regulatory and industrial sectors. The Journal of Dietary Supplements (formerly the Journal of Nutraceuticals, Functional & Medical Foods) was recently retitled to reflect the growing field of dietary supplement research. The journal is published by Informa Healthcare , a leading provider of academic and scientific information via nearly 200 peer-reviewed research journals that focus on pharmaceuticals, medicine and the life sciences. Chief editor Catherine Ulbricht is the founder of Natural Standard, an international research collaboration that aggregates and synthesizes data on complementary and alternative therapies. Dr. Wendy Chao is Associate Editor of the publication. The distinguished editorial board includes the following internationally known scientists: Brent A Bauer, MD, FACP, Mark Blumenthal, William Benda, MD, Edzard Ernst, MD, PhD, FRCP, FRCP (Edin.), Bradly Jacobs, MD, MPH, Karta Purkh S. Khalsa, CD-N, RH Journal of Dietary Supplements


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009